129 related articles for article (PubMed ID: 10077451)
1. Geranylgeranylpyrophosphate plays a key role for the G1 to S transition in vascular smooth muscle cells.
Terano T; Shiina T; Noguchi Y; Tanaka T; Tatsuno I; Saito Y; Yasuda T; Kitagawa M; Hirai A
J Atheroscler Thromb; 1998; 5(1):1-6. PubMed ID: 10077451
[TBL] [Abstract][Full Text] [Related]
2. Geranylgeranylpyrophosphate, a metabolite of mevalonate, regulates the cell cycle progression and DNA synthesis in human lymphocytes.
Tatsuno I; Tanaka T; Oeda T; Yasuda T; Kitagawa M; Saito Y; Hirai A
Biochem Biophys Res Commun; 1997 Dec; 241(2):376-82. PubMed ID: 9425279
[TBL] [Abstract][Full Text] [Related]
3. Effect of pravastatin on type IV collagen secretion and mesangial cell proliferation.
Nishimura M; Tanaka T; Yasuda T; Kurakata S; Kitagawa M; Yamada K; Saito Y; Hirai A
Kidney Int Suppl; 1999 Jul; 71():S97-100. PubMed ID: 10412748
[TBL] [Abstract][Full Text] [Related]
4. Collagen secretion and growth of mesangial cells require geranylgeranylpyrophosphate.
Nishimura M; Tanaka T; Yasuda T; Kurakata S; Kitagawa M; Yamada K; Saito Y; Hirai A
Kidney Int; 1999 Feb; 55(2):520-8. PubMed ID: 9987076
[TBL] [Abstract][Full Text] [Related]
5. Geranylgeranyl-pyrophosphate, an isoprenoid of mevalonate cascade, is a critical compound for rat primary cultured cortical neurons to protect the cell death induced by 3-hydroxy-3-methylglutaryl-CoA reductase inhibition.
Tanaka T; Tatsuno I; Uchida D; Moroo I; Morio H; Nakamura S; Noguchi Y; Yasuda T; Kitagawa M; Saito Y; Hirai A
J Neurosci; 2000 Apr; 20(8):2852-9. PubMed ID: 10751437
[TBL] [Abstract][Full Text] [Related]
6. HMG CoA reductase inhibitor-induced myotoxicity: pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture.
Flint OP; Masters BA; Gregg RE; Durham SK
Toxicol Appl Pharmacol; 1997 Jul; 145(1):99-110. PubMed ID: 9221829
[TBL] [Abstract][Full Text] [Related]
7. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase.
Laufs U; Liao JK
J Biol Chem; 1998 Sep; 273(37):24266-71. PubMed ID: 9727051
[TBL] [Abstract][Full Text] [Related]
8. Statins inhibit blastocyst formation by preventing geranylgeranylation.
Alarcon VB; Marikawa Y
Mol Hum Reprod; 2016 May; 22(5):350-63. PubMed ID: 26908642
[TBL] [Abstract][Full Text] [Related]
9. 3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture.
Guijarro C; Blanco-Colio LM; Ortego M; Alonso C; Ortiz A; Plaza JJ; Díaz C; Hernández G; Egido J
Circ Res; 1998 Sep; 83(5):490-500. PubMed ID: 9734471
[TBL] [Abstract][Full Text] [Related]
10. Activation of cyclin-dependent kinase 2 (Cdk2) in growth-stimulated rat astrocytes. Geranylgeranylated Rho small GTPase(s) are essential for the induction of cyclin E gene expression.
Tanaka T; Tatsuno I; Noguchi Y; Uchida D; Oeda T; Narumiya S; Yasuda T; Higashi H; Kitagawa M; Nakayama K; Saito Y; Hirai A
J Biol Chem; 1998 Oct; 273(41):26772-8. PubMed ID: 9756921
[TBL] [Abstract][Full Text] [Related]
11. Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins).
Eberlein M; Heusinger-Ribeiro J; Goppelt-Struebe M
Br J Pharmacol; 2001 Aug; 133(7):1172-80. PubMed ID: 11487529
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of serotonin-induced mitogenesis, migration, and ERK MAPK nuclear translocation in vascular smooth muscle cells by atorvastatin.
Li M; Liu Y; Dutt P; Fanburg BL; Toksoz D
Am J Physiol Lung Cell Mol Physiol; 2007 Aug; 293(2):L463-71. PubMed ID: 17545489
[TBL] [Abstract][Full Text] [Related]
13. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (pravastatin) inhibits endothelial cell proliferation dependent on G1 cell cycle arrest.
Asakage M; Tsuno NH; Kitayama J; Kawai K; Okaji Y; Yazawa K; Kaisaki S; Takahashi K; Nagawa H
Anticancer Drugs; 2004 Jul; 15(6):625-32. PubMed ID: 15205608
[TBL] [Abstract][Full Text] [Related]
14. Importance of geranylgeranyl pyrophosphate for mesangial cell DNA synthesis.
Massy ZA; Guijarro C; Oda H; Kasiske BL; Keane WF; O'Donnell MP
Kidney Int Suppl; 1999 Jul; 71():S80-3. PubMed ID: 10412744
[TBL] [Abstract][Full Text] [Related]
15. Regulation of geranylgeranyl pyrophosphate synthase in the proliferation of rat FRTL-5 cells: involvement of both cAMP-PKA and PI3-AKT pathways.
Fuse M; Tanaka T; Shibata T; Yoshida T; Noguchi Y; Misawa N; Yasuda T; Saito Y; Kohn LD; Tatsuno I
Biochem Biophys Res Commun; 2004 Mar; 315(4):1147-53. PubMed ID: 14985133
[TBL] [Abstract][Full Text] [Related]
16. Tissue factor induction by aggregated LDL depends on LDL receptor-related protein expression (LRP1) and Rho A translocation in human vascular smooth muscle cells.
Camino-López S; Llorente-Cortés V; Sendra J; Badimon L
Cardiovasc Res; 2007 Jan; 73(1):208-16. PubMed ID: 17141748
[TBL] [Abstract][Full Text] [Related]
17. Geranylgeranylated rho small GTPase(s) are essential for the degradation of p27Kip1 and facilitate the progression from G1 to S phase in growth-stimulated rat FRTL-5 cells.
Hirai A; Nakamura S; Noguchi Y; Yasuda T; Kitagawa M; Tatsuno I; Oeda T; Tahara K; Terano T; Narumiya S; Kohn LD; Saito Y
J Biol Chem; 1997 Jan; 272(1):13-6. PubMed ID: 8995216
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the RhoA/Rho-associated, coiled-coil-containing protein kinase-1 pathway is involved in the therapeutic effects of simvastatin on pulmonary arterial hypertension.
Liu WH; Xu XH; Luo Q; Zhang HL; Wang Y; Xi QY; Zhao ZH; Liu ZH
Clin Exp Hypertens; 2018; 40(3):224-230. PubMed ID: 29319354
[TBL] [Abstract][Full Text] [Related]
19. Cerivastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase, inhibits endothelial cell proliferation induced by angiogenic factors in vitro and angiogenesis in in vivo models.
Vincent L; Soria C; Mirshahi F; Opolon P; Mishal Z; Vannier JP; Soria J; Hong L
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):623-9. PubMed ID: 11950701
[TBL] [Abstract][Full Text] [Related]
20. Effects of farnesyl pyrophosphate accumulation on calvarial osteoblast differentiation.
Weivoda MM; Hohl RJ
Endocrinology; 2011 Aug; 152(8):3113-22. PubMed ID: 21586555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
